问题聘请战略规划顾问 › 医疗服务提供商

聘请战略规划顾问
in 医疗服务提供商

计划列出按归因人头分配的活动,而决策会根据每集成本设定接受或退出哪些基于价值的合同。 对医疗服务提供商而言,问题出现在特定位置。承载答案的数字是每集成本和 payer mix,行业特有的复杂之处在于,已在38,000人头上接受 downside risk,却缺少定价所需的每集成本数据。这个问题的通用版本与您实际面对的版本,前期动作不同。

简短回答

计划列出按归因人头分配的活动,而决策会根据每集成本设定接受或退出哪些基于价值的合同。 对医疗服务提供商而言,问题出现在特定位置。承载答案的数字是每集成本和 payer mix,行业特有的复杂之处在于,已在38,000人头上接受 downside risk,却缺少定价所需的每集成本数据。这个问题的通用版本与您实际面对的版本,前期动作不同。

每年临床和运营部门提交增加 panel 容量或支持人员的需求,总额超过可用贡献,差额被全面削减,因此发布的文件显示的是活动水平,而非 payer mix 或合同类型的选择。

聘请顾问来挖掘缺失的每集成本数据,以便 CFO 或医务主任评估哪些归因人头可持续,但真正的障碍是,任何明确的 panel 缩减或合同退出,都会对某一服务线造成可见损失。

寻求外部帮助的第二个原因是,整理五年 episode 成本、按 payer mix 分段、计算每位 provider 贡献的工作量巨大,而领导层仍需同时处理日常运营;这种分析组装工作,即便底层算术已可自动化,外部方仍能节省可量化的工时。

Corporate Strategy & Transformation 构建这些分段案例,展示每项合同或 panel 调整需满足的条件,而不主持会议,也不强迫医务主任和 CFO 承担缩减归因人头的政治代价。

如何判断这确实是你的问题

这三者同时出现才是标志。单独一个通常指向其他问题。

✓ 最近一次规划周期未对 panel 规模或 payer mix 做出明确调整,尽管已知38,000归因人头的每集成本数据存在缺口。
✓ 同样的基于价值合同改进清单每年出现,却无每位 provider 贡献或 episode 级成本的记录进展。
✓ 来年预算分配在任何重新计算哪些合同或 panel 可按当前每集成本维持之前已定稿。

通常会让情况更糟的做法。 请来协调人改善会议流程,而实际障碍是,一旦每集成本数字可见,是否拥有要求 CFO 或医务主任缩减 panel 规模或放弃合同的权力。

Who this is for — and who it is not

It is for you if you run or finance a healthcare provider and the last plan contained no decision to stop doing something. It is the situation where the numbers are available but nobody has put them in an order that produces a decision.

It is not for you if Percision is the wrong tool if you already know the answer and only need execution capacity, or if the business is pre-revenue — then the constraint is evidence about the market, not analysis of your own figures. Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library. Also wrong if you need facilitation, politics, or someone to sit with a lender or buyer. Those are human jobs.

Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library.

实际运行分析时的样子

Below is an excerpt from a real run of this analysis on 一家医疗服务提供商. It is a sample profile rather than a customer, and it is engine output translated from English — this is the format you get, on your own numbers.

The subject is Cedar Ridge Health Partners, a sample company profile used for testing rather than a customer — 38,000 attributed lives under value-based contracts.

Excerpt from a real Percision run · Pricing Strategy · sample company profile

The move. Protect and grow the 34% operating-income ASC engine by replacing retiring surgeons and steering 212k attributed lives to the ASC within 24 months.

What the run committed to
Investment required$3.0-4.0M total over 24 months ($1.8-2.2M surgeon succession + retention bonuses; $1.2-1.8M referral-optimization platform and analytics)
Expected returnIncremental $4.8-6.4M annual ASC contribution margin by Month 24; payback 14-18 months on $3.0-4.0M investment; lifts group operating margin from 4.2% to 5.8-6.4%.
Revenue, year 1$202-208M (ASC case volume +4-6%)
Revenue, year 2$212-220M (ASC case volume +6-8%; physician retention +2-3%)
Revenue, year 3$225-235M (ASC contribution ≥40% of operating income)
Exit criteriaStrategy abandoned if, by Month 12, fewer than two qualified orthopaedic surgeon candidates have signed LOIs OR if ASC case volume has not grown at least 2% YoY; in either case, board must decide within 30 days whether to pivot to hospital-system sale process at 8-10× EBITDA.

This is one move out of a full analysis. Read a complete report — every page, no email required.

引擎如何处理这个问题

This question routes to Corporate Strategy & Transformation, one of 29 engagements the platform runs. For 医疗服务提供商 it works through cost per episode, payer mix, panel size and contribution per provider, then produces the sequence rather than a list of options — which move first, what it funds, and the observation that would say the sequence is wrong.

You watch the analysis get built before paying anything. 在此阅读完整报告 if you would rather see the depth first.

人们关于此问题的常见提问

战略规划顾问收费多少?

独立协调人主持 offsite 并产出计划,通常£8k–£30k。完整规划周期含分析的公司收费£60k–£200k。区间宽是因为两项工作不同:一项是协调,一项是取证。比较报价前先确定自己缺哪一项,因为选错的廉价版本仍是浪费。

战略计划应多长?

短到权衡可见即可。有用的计划说明将在哪里取胜、将停止什么,以及必须成立的两三件事。典型规划文件的长度大多是支持已定决策的证据,这些内容属于附录,无人需要读第二遍。

计划应覆盖三年还是一年?

方向定三年,资源承诺一年。三年财务细节在几乎所有业务中都是虚构精度,将其视为承诺会使计划脆弱。真正需要三年视角的部分是产能、资本和能力,因为这些无法在一年内改变。

Is this different in healthcare providers than in other industries?

Materially, yes. Downside risk has been accepted on 38,000 lives without the cost-per-episode data needed to price it — which changes both the diagnosis and the order of the fixes. The metrics that decide it here are cost per episode, payer mix, panel size, and an answer built on industry-general benchmarks will usually point at the wrong one first.

What data do I need before this analysis is worth running for a healthcare provider?

Less than most people expect. Your last twelve months of revenue and cost split the way you already split it, plus whatever you hold on cost per episode and payer mix. The analysis is explicit about what it is assuming where your data stops, which is more useful than waiting for numbers you may never have.

When is Percision the wrong tool?

Percision is the wrong tool if you already know the answer and only need execution capacity, or if the business is pre-revenue — then the constraint is evidence about the market, not analysis of your own figures. Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library. Also wrong if you need facilitation, politics, or someone to sit with a lender or buyer. Those are human jobs.

Does Percision replace a lawyer, tax advisor, auditor, or AI implementation team?

Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library.

这是你业务中的情况吗?

Describe the situation in your own words and we will tell you which analysis answers it — before you sign up for anything.

Describe my situation →

Prefer to skip ahead? Go straight to the free diagnostic.

English · Español · Deutsch · Português · Français · Italiano · Nederlands · 日本語 · 한국어 · 中文 · Polski · Svenska · Türkçe · العربية · Tiếng Việt · ไทย · हिन्दी · עברית